Blog

atai Life Sciences Announces First Participant Dosed in Phase 1b Trial of VLS-01

Mar 4 • 3 min read

NEW YORK and BERLIN, March 04, 2024 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced that the first healthy participant has been dosed in the Phase 1b trial of VLS-01, an oral transmucosal film (OTF) formulation of N,N-dimethyltryptamine (DMT). The…

BetterLife’s 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton University

Mar 4 • 3 min read

VANCOUVER, British Columbia, March 04, 2024 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge treatments for mental disorders, today announced that its development of 2-bromo-LSD was highlighted in Carleton University’s articled titled “Beyond the Magic of Mushrooms: Using Psychedelic…

Ketamine’s Short and Long-Term Effects on Depression

Mar 1 • 2 min read

A groundbreaking study by Northwestern Medicine has unveiled the intricate processes that enable ketamine to produce both immediate and enduring antidepressant effects. This breakthrough could lead to the development of novel, safer depression therapies. Distinct from conventional antidepressants, which often require weeks to manifest effects, ketamine offers rapid relief and maintains its benefits over time,…

Braxia Scientific Corp Shows Resilience Amid Financial Challenges

Mar 1 • 3 min read

Braxia Scientific Corp., a name that has been under significant scrutiny due to its financial health, recently unveiled its financial results for the quarter ending December 31, 2023. Amidst a challenging financial landscape, the company has shown a glimmer of resilience, reporting a modest increase in revenue by 0.7% to $0.492 million for the quarter….

Silo Wellness Announces Extension of Kaya/NUGL LOI; Annual Filings Delay

Feb 29 • 3 min read

Springfield, Oregon–(Newsfile Corp. – February 27, 2024) – Silo Wellness Inc. (CSE: SILO) (OTCQB: SILFF) (FSE: 3K7A) (“Silo” or “the Company”), a leading global psychedelics wellness company, announces that the Letter of Intent (LOI) to acquire NUGL (Kaya Group in Jamaica) previously announced on August 29, 2023 has been extended through June 1, 2024. The extension provides…

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556